Effects of the SGLT2 inhibitor dapagliflozin on cardiac function evaluated by impedance cardiography in patients with type 2 diabetes. Secondary analysis of a randomized placebo-controlled trial

Overview of attention for article published in Cardiovascular Diabetology, August 2019

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 21 Dimensions

Readers on

mendeley: 136 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 4,687 followers.

【SGLT2阻害薬が心機能に及ぼす影響は？：小規模RCT/ Cariovasc Diabetol】２型DM 32例ランダム化、12週観察：SGLT2阻害薬はプラセボに比べ、１回拍出量、心係数、EF [いずれもインピーダンスカルジオグラフィー評価] を改善せず。 https://t.co/SkexPhh3ct